HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Sawada Selected Research

Drug Eruptions (Drug Eruption)

7/2021Diagnostic Tools and Biomarkers for Severe Drug Eruptions.
1/2021High S100A2 expression in keratinocytes in patients with drug eruption.
5/2018Drug eruption caused by enzalutamide: A case and literature review of androgen receptor inhibitor-related drug eruptions.
11/2017Maculopapular type drug eruption caused by garenoxacin mesilate hydrate: A case report and literature review.
8/2017Two cases of eczematous drug eruption caused by oral tacrolimus administration.
8/2017First case of drug eruption due to ipragliflozin: Case report and review of the literature.
7/2017Drug eruption caused by memantine.
2/2017A possible role of IL-23-producing cells in a patient with psoriasiform drug eruption due to tazobactam and piperacillin hydrate: a case study and literature review.
2/2017Lichenoid drug eruption caused by adalimumab: a case report and literature review.
2/2017Drug eruption caused by secukinumab.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Sawada Research Topics

Disease

24Neoplasms (Cancer)
01/2022 - 12/2012
21Drug Eruptions (Drug Eruption)
07/2021 - 08/2009
13Hepatocellular Carcinoma (Hepatoma)
06/2017 - 07/2012
8Inflammation (Inflammations)
04/2022 - 07/2014
7Psoriasis (Pustulosis Palmaris et Plantaris)
04/2022 - 05/2014
7Melanoma (Melanoma, Malignant)
01/2022 - 01/2015
6Skin Diseases (Skin Disease)
01/2022 - 07/2009
5Dermatitis
01/2018 - 05/2012
5Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2014 - 04/2011
4Lymphatic Metastasis
04/2022 - 12/2019
4Neoplasm Metastasis (Metastasis)
08/2019 - 03/2016
4Urticaria (Hives)
01/2014 - 11/2010
3Skin Neoplasms (Skin Cancer)
01/2022 - 11/2021
3Obesity
01/2022 - 05/2021
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2021 - 09/2012
2Stevens-Johnson Syndrome (Lyell's Syndrome)
07/2021 - 05/2014
2Atopic Dermatitis (Atopic Eczema)
11/2019 - 01/2019
2Colorectal Neoplasms (Colorectal Cancer)
02/2019 - 03/2014
2Pseudolymphoma
05/2016 - 05/2009
2Acute Generalized Exanthematous Pustulosis
02/2016 - 01/2016
2Hypohidrosis
01/2014 - 01/2011
2Tinea (Ringworm)
07/2013 - 07/2012
1Gallbladder Neoplasms (Gallbladder Cancer)
04/2022
1Klatskin Tumor
04/2022
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
03/2022
1Alopecia Areata
01/2022
1Foreign Bodies (Foreign Body)
01/2022
1Hidradenitis Suppurativa
01/2022
1Sarcoma (Soft Tissue Sarcoma)
12/2021
1Bites and Stings (Sting)
11/2021
1Angioedema
08/2021
1IgA Vasculitis (Purpura, Schoenlein Henoch)
07/2021
1COVID-19
07/2021
1Virus Diseases (Viral Diseases)
07/2021
1Vasculitis (Vasculitides)
07/2021
1Autoimmune Diseases (Autoimmune Disease)
07/2021
1Extramammary Paget Disease (Paget Disease, Extramammary)
06/2021
1Merkel Cell Carcinoma
05/2021
1Basal Cell Carcinoma (Rodent Ulcer)
05/2021
1Sepsis (Septicemia)
03/2021

Drug/Important Bio-Agent (IBA)

10GlypicansIBA
03/2018 - 07/2012
10Peptides (Polypeptides)IBA
03/2018 - 11/2012
10Protein Subunit VaccinesIBA
01/2017 - 07/2012
7Biomarkers (Surrogate Marker)IBA
07/2021 - 03/2014
5CytokinesIBA
04/2022 - 11/2010
5Pharmaceutical PreparationsIBA
03/2022 - 05/2009
5AntigensIBA
01/2022 - 12/2012
4InterferonsIBA
11/2021 - 01/2015
4Imiquimod (Aldara)FDA LinkGeneric
01/2021 - 07/2014
4NivolumabIBA
12/2018 - 01/2015
4Cholinergic Agents (Cholinergics)IBA
01/2014 - 11/2010
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2022 - 01/2020
3LigandsIBA
07/2021 - 01/2014
3Cell Adhesion Molecule-1IBA
05/2021 - 01/2018
3secukinumabIBA
08/2018 - 02/2017
3Interleukin-17 (Interleukin 17)IBA
01/2018 - 07/2012
3Interleukin-23 (Interleukin 23)IBA
01/2018 - 07/2014
3VaccinesIBA
01/2017 - 01/2015
3Carcinoembryonic AntigenIBA
10/2013 - 07/2012
2Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 08/2021
2Glutens (Glutelin)IBA
01/2022 - 05/2021
2Adalimumab (Humira)FDA Link
01/2022 - 02/2017
2Cell Adhesion MoleculesIBA
11/2021 - 05/2021
2Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
11/2021 - 01/2018
2Proteins (Proteins, Gene)FDA Link
07/2021 - 05/2021
2Granzymes (Granzyme)IBA
07/2021 - 03/2016
2PerforinIBA
07/2021 - 03/2016
2Antimicrobial PeptidesIBA
06/2021 - 07/2012
2Dietary FiberFDA Link
05/2021 - 05/2021
2BilirubinIBA
08/2019 - 01/2017
2HLA-A2 Antigen (HLA A2 Antigen)IBA
03/2018 - 03/2014
2Immune Checkpoint InhibitorsIBA
03/2018 - 09/2015
25S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA
01/2018 - 10/2015
2Tacrolimus (Prograf)FDA LinkGeneric
08/2017 - 02/2016
2tocilizumab (atlizumab)FDA Link
10/2016 - 05/2016
2EpitopesIBA
01/2016 - 03/2014
1GemcitabineFDA Link
04/2022
1BismuthIBA
04/2022
1MetalsIBA
01/2022
1Interferon Type IIBA
11/2021
1Histamine (Histamine Dihydrochloride)FDA Link
08/2021
1BradykininIBA
08/2021
1HMGB1 Protein (HMG1)IBA
07/2021
1MicroRNAs (MicroRNA)IBA
07/2021
1Immunoglobulin A (IgA)IBA
07/2021
1dermcidinIBA
06/2021
1AcidsIBA
05/2021
1Fatty AlcoholsIBA
05/2021
1Immunoglobulins (Immunoglobulin)IBA
05/2021
1telaprevirIBA
01/2021
1ChromatinIBA
01/2021
1CA-19-9 Antigen (CA 19-9 Antigen)IBA
11/2020

Therapy/Procedure

13Therapeutics
04/2022 - 05/2009
10Immunotherapy
01/2022 - 07/2012
3Hepatectomy
11/2020 - 01/2017
2Neoadjuvant Therapy
04/2022 - 12/2019
2Liver Transplantation
03/2021 - 02/2016
2Radiotherapy
08/2019 - 03/2013
1Lymph Node Excision (Lymph Node Dissection)
04/2022
1Cholecystectomy
04/2022